Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 12 papers were listed this time. Here's a few in our areas of research interest:
Rombach SM, Hollak CE, Linthorst GE, et al. Cost-effectiveness of enzyme replacement therapy for Fabry disease. Orphanet J Rare Dis. 2013 Feb 19;8(1):29. [Epub ahead of print] PMID: 23421808
de Groot NL, van Haalen HG, Spiegel BM, et al. Gastroprotection in Low-Dose Aspirin Users for Primary and Secondary Prevention of ACS: Results of a Cost-Effectiveness Analysis Including Compliance. Cardiovasc Drugs Ther. 2013 Feb 16. [Epub ahead of print] PMID: 23417566
Magnuson EA, Farkouh ME, Fuster V, et al. Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial. Circulation. 2013 Feb 19;127(7):820-31. Epub 2012 Dec 31.
